At the Aspen Security Forum and in an accompanying Bloomberg interview this week, US Trade Representative Jamieson Greer reiterated that the new managed trade framework with China will focus on purchase commitments and tariffs.
The Office of the US Trade Representative (USTR) will soon formally review extending the first batch of Section 301 tariffs covering $34 billion worth of imports from China from Trump’s first term, including medical devices, robotics, and aerospace products.
The National Defense Authorization Act (NDAA) for 2027 is coming into focus after the House and Senate armed services committees advanced their versions of the bill earlier this month.
The Department of Defense (DOD) on Monday released an updated 1260H list, which designates Chinese military-linked companies. Chinese tech giants Alibaba and Baidu, automaker BYD, biotech firm WuXi AppTec, robotics company RoboSense Technology, and router maker TP-Link are among those newly added.
The Office of the US Trade Representative on Tuesday issued a Federal Register notice requesting public comment on the planned US-China Board of Trade. The mechanism, a key deliverable of the recent presidential summit in Beijing, aims to identify $30 billion of non-sensitive goods to reduce or eliminate tariffs on.
The United States and China agreed to pursue “constructive strategic stability” during President Donald Trump’s visit to Beijing last week, announcing purchase deals and plans for trade and investment boards. Both sides confirmed that President Xi Jinping would visit the White House in September.
Tension is building just a week before Trump’s high-stakes visit to China, and US officials are tempering expectations. Treasury Secretary Scott Bessent on Monday downplayed deliverables for the summit, set for May 14 to 15, noting only that the United States will “push forward the consensus” reached with China last year.
The House Foreign Affairs Committee on Wednesday advanced all 23 export controls related bills included in its markup, sending a strong message of support for enhanced controls and enforcement. Several bills, including the ADVERSARIES Act and STRIDE Act, passed unanimously, with most others receiving broad, bipartisan support.
This week, the United States and China affirmed that President Donald Trump’s visit to China is expected to go ahead despite mixed signals from the administration over China’s relationship with Iran. Trump on Tuesday met with US Ambassador to China David Perdue in Washington to discuss summit planning, but no details have been shared.
Speaking at the Hudson Institute on Tuesday, US Trade Representative Jamieson Greer outlined some of the key anticipated deliverables for President Donald Trump’s visit to China next month. Greer reaffirmed that the United States would push for a board of trade with China to identify non-sensitive sectors for bilateral trade.
